BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lawal B, Lee CY, Mokgautsi N, Sumitra MR, Khedkar H, Wu ATH, Huang HS. mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2',4'-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications. Front Oncol 2021;11:656738. [PMID: 33842373 DOI: 10.3389/fonc.2021.656738] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Lawal B, Wang YC, Wu ATH, Huang HS. Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives. Front Pharmacol 2021;12:691234. [PMID: 34512327 DOI: 10.3389/fphar.2021.691234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lawal B, Kuo YC, Sumitra MR, Wu ATH, Huang HS. In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer. J Inflamm Res 2021;14:4901-13. [PMID: 34588796 DOI: 10.2147/JIR.S329401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lawal B, Kuo YC, Wu ATH, Huang HS. BC-N102 suppress breast cancer tumorigenesis by interfering with cell cycle regulatory proteins and hormonal signaling, and induction of time-course arrest of cell cycle at G1/G0 phase. Int J Biol Sci 2021;17:3224-38. [PMID: 34421361 DOI: 10.7150/ijbs.62808] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Onikanni AS, Lawal B, Olusola AO, Olugbodi JO, Sani S, Ajiboye BO, Ilesanmi OB, Alqarni M, Mostafa-Hedeab G, Obaidullah AJ, Batiha GE, Wu ATH. Sterculia tragacantha Lindl Leaf Extract Ameliorates STZ-Induced Diabetes, Oxidative Stress, Inflammation and Neuronal Impairment. J Inflamm Res 2021;14:6749-64. [PMID: 34916823 DOI: 10.2147/JIR.S319673] [Reference Citation Analysis]
5 Gonçalves DA, Jasiulionis MG, Melo FHM. The Role of the BH4 Cofactor in Nitric Oxide Synthase Activity and Cancer Progression: Two Sides of the Same Coin. Int J Mol Sci 2021;22:9546. [PMID: 34502450 DOI: 10.3390/ijms22179546] [Reference Citation Analysis]
6 Alorabi M, Mohammed DS, Mostafa-hedeab G, El-sherbeni SA, Negm WA, Mohammed AIA, Al-kuraishy HM, Nasreldin N, Alotaibi SS, Lawal B, Batiha GE, Conte-junior CA, Pasciu V. Combination Treatment of Omega-3 Fatty Acids and Vitamin C Exhibited Promising Therapeutic Effect against Oxidative Impairment of the Liver in Methotrexate-Intoxicated Mice. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/4122166] [Reference Citation Analysis]
7 Lawal B, Tseng SH, Olugbodi JO, Iamsaard S, Ilesanmi OB, Mahmoud MH, Ahmed SH, Batiha GE, Wu ATH. Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance. Cancers (Basel) 2021;13:4124. [PMID: 34439277 DOI: 10.3390/cancers13164124] [Reference Citation Analysis]
8 Yeh YC, Lawal B, Hsiao M, Huang TH, Huang CF. Identification of NSP3 (SH2D3C) as a Prognostic Biomarker of Tumor Progression and Immune Evasion for Lung Cancer and Evaluation of Organosulfur Compounds from Allium sativum L. as Therapeutic Candidates. Biomedicines 2021;9:1582. [PMID: 34829812 DOI: 10.3390/biomedicines9111582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lawal B, Kuo YC, Tang SL, Liu FC, Wu ATH, Lin HY, Huang HS. Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration. Cells 2021;10:2873. [PMID: 34831096 DOI: 10.3390/cells10112873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lawal B, Wu ATH, Huang HS. Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule. Front Immunol 2022;13:872470. [PMID: 35655775 DOI: 10.3389/fimmu.2022.872470] [Reference Citation Analysis]
11 Wu ATH, Lawal B, Wei L, Wen YT, Tzeng DTW, Lo WC. Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate. Pharmaceutics 2021;13:1555. [PMID: 34683848 DOI: 10.3390/pharmaceutics13101555] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wu ATH, Lawal B, Tzeng YM, Shih CC, Shih CM. Identification of a Novel Theranostic Signature of Metabolic and Immune-Inflammatory Dysregulation in Myocardial Infarction, and the Potential Therapeutic Properties of Ovatodiolide, a Diterpenoid Derivative. Int J Mol Sci 2022;23:1281. [PMID: 35163208 DOI: 10.3390/ijms23031281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Olugbodi JO, Olaleye MT, Mostafa-Hedeab G, Alqarni M, Ilesanmi OB, Batiha GE, Akinmoladun AC. Glyphaeaside C- enriched extract of Glyphaea brevis restored the antioxidant and reproductive integrity of 1,4-Dinitrobenzene-intoxicated rats. Biomed Pharmacother 2022;145:112359. [PMID: 34887141 DOI: 10.1016/j.biopha.2021.112359] [Reference Citation Analysis]
14 Wu ATH, Huang HS, Wen YT, Lawal B, Mokgautsi N, Huynh TT, Hsiao M, Wei L. A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling. Cells 2021;10:2391. [PMID: 34572040 DOI: 10.3390/cells10092391] [Reference Citation Analysis]
15 Chiao CC, Liu YH, Phan NN, An Ton NT, Ta HDK, Anuraga G, Minh Xuan DT, Fitriani F, Putri Hermanto EM, Athoillah M, Andriani V, Ajiningrum PS, Wu YF, Lee KH, Chuang JY, Wang CY, Kao TJ. Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer. Diagnostics (Basel) 2021;11:2220. [PMID: 34943457 DOI: 10.3390/diagnostics11122220] [Reference Citation Analysis]
16 Chen JH, Wu ATH, Lawal B, Tzeng DTW, Lee JC, Ho CL, Chao TY. Identification of Cancer Hub Gene Signatures Associated with Immune-Suppressive Tumor Microenvironment and Ovatodiolide as a Potential Cancer Immunotherapeutic Agent. Cancers (Basel) 2021;13:3847. [PMID: 34359748 DOI: 10.3390/cancers13153847] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Oleksak P, Nepovimova E, Chrienova Z, Musilek K, Patocka J, Kuca K. Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015–2021). European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114498] [Reference Citation Analysis]
18 Khedkar HN, Wang YC, Yadav VK, Srivastava P, Lawal B, Mokgautsi N, Sumitra MR, Wu ATH, Huang HS. In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1. Int J Mol Sci 2021;22:5895. [PMID: 34072728 DOI: 10.3390/ijms22115895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wu SY, Lin KC, Lawal B, Wu ATH, Wu CZ. MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types. Comput Struct Biotechnol J 2021;19:4970-83. [PMID: 34584637 DOI: 10.1016/j.csbj.2021.08.047] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Olugbodi JO, Samaila K, Lawal B, Anunobi OO, Baty RS, Ilesanmi OB, Batiha GE. Computational and Preclinical Evidence of Anti-ischemic Properties of L-Carnitine-Rich Supplement via Stimulation of Anti-inflammatory and Antioxidant Events in Testicular Torsed Rats. Oxid Med Cell Longev 2021;2021:5543340. [PMID: 34326917 DOI: 10.1155/2021/5543340] [Reference Citation Analysis]